Meningococcal serogroup B vaccines

被引:0
|
作者
Dommergues, M. -A. [1 ]
机构
[1] Ctr Hosp Versailles, F-78150 Le Chesnay, France
来源
ARCHIVES DE PEDIATRIE | 2012年 / 19卷
关键词
RECOMBINANT PROTEIN; TAILOR-MADE; COVERAGE; SAFETY;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The diversity and antigenic variability of Neisseria meningitidis serogroup B strains around the world has been a major challenge to developing a vaccine with broad coverage. Outer-membrane vesicle vaccines appear to be safe and effective but are strain-specific vaccines and used in delimited areas. Also, recombinant protein vaccines such as factor H binding protein, given alone or in combination with others antigens have been developed and may be effective against the majority of group B strains. (c) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S65 / S69
页数:5
相关论文
共 50 条
  • [1] Serogroup B meningococcal vaccines
    Zimmer, Shanta M.
    Stephens, David S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (08) : 733 - 739
  • [2] Translating meningococcal serogroup B vaccines for healthcare professionals
    Safadi, Marco Aurelio P.
    Martinon-Torres, Federico
    Serra, Lidia
    Burman, Cynthia
    Presa, Jessica
    EXPERT REVIEW OF VACCINES, 2021, 20 (04) : 401 - 414
  • [3] Emerging experience with meningococcal serogroup B protein vaccines
    Toneatto, Daniela
    Pizza, Mariagrazia
    Masignani, Vega
    Rappuoli, Rino
    EXPERT REVIEW OF VACCINES, 2017, 16 (05) : 433 - 451
  • [4] Serogroup B meningococcal vaccines-an unfinished story
    Sadarangani, Manish
    Pollard, Andrew J.
    LANCET INFECTIOUS DISEASES, 2010, 10 (02): : 112 - 124
  • [5] Understanding immunogenicity assessments for meningococcal serogroup B vaccines
    Balmer, Paul
    Beeslaar, Johannes
    Findlow, Jamie
    Srivastava, Amit
    POSTGRADUATE MEDICINE, 2020, 132 (02) : 184 - 191
  • [6] Meningococcal serogroup B vaccines: Estimating breadth of coverage
    Donald, Robert G. K.
    Hawkins, Julio Cesar
    Hao, Li
    Liberator, Paul
    Jones, Thomas R.
    Harris, Shannon L.
    Perez, John L.
    Eiden, Joseph J.
    Jansen, Kathrin U.
    Anderson, Annaliesa S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (02) : 255 - 265
  • [7] Meningococcal serogroup B vaccines: will they live up to expectations?
    Zollinger, Wendell D.
    Poolman, Jan T.
    Maiden, Martin C. J.
    EXPERT REVIEW OF VACCINES, 2011, 10 (05) : 559 - 561
  • [8] UNDERSTANDING PATIENT PREFERENCES FOR MENINGOCOCCAL SEROGROUP B VACCINES
    Johnson, Reed
    Fairchild, Angelyn
    Huang, Liping
    Srivastava, Amit
    JOURNAL OF ADOLESCENT HEALTH, 2020, 66 (02) : S141 - S142
  • [9] Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines
    Oviedo-Orta, Ernesto
    Ahmed, Sohail
    Rappuoli, Rino
    Black, Steven
    VACCINE, 2015, 33 (31) : 3628 - 3635
  • [10] Recent developments in vaccines to prevent meningococcal serogroup B infections
    Vermont, CL
    van den Dobbelsteen, GPJM
    de Groot, R
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (01) : 33 - 38